Cargando…

Analytical Validation Considerations of Multiplex Mass-Spectrometry-Based Proteomic Platforms for Measuring Protein Biomarkers

[Image: see text] Protein biomarker discovery and validation in current omics era are vital for healthcare professionals to improve diagnosis, detect cancers at an early stage, identify the likelihood of cancer recurrence, stratify stages with differential survival outcomes, and monitor therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boja, Emily S., Fehniger, Thomas E., Baker, Mark S., Marko-Varga, György, Rodriguez, Henry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2014
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261948/ https://www.ncbi.nlm.nih.gov/pubmed/25171765 http://dx.doi.org/10.1021/pr500753r

Ejemplares similares

Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels
por: Rezeli, Melinda, et al.
Publicado: (2011)

Localization of tamoxifen in human breast cancer tumors by MALDI mass spectrometry imaging
por: Végvári, Ákos, et al.
Publicado: (2016)

Building the basis for proteomics in personalized medicine for targeted treatment
por: Kwon, Ho Jeong, et al.
Publicado: (2016)

Fine Mapping the Spatial Distribution and Concentration of Unlabeled Drugs within Tissue Micro-Compartments Using Imaging Mass Spectrometry
por: Nilsson, Anna, et al.
Publicado: (2010)

Endogenous expression mapping of malignant melanoma by mass spectrometry imaging
por: Sugihara, Yutaka, et al.
Publicado: (2018)

Affinity-Bead Assisted Mass Spectrometry (Affi-BAMS): A Multiplexed Microarray Platform for Targeted Proteomics
por: Hamza, Ghaith M., et al.
Publicado: (2020)

A Cross-platform Toolkit for Mass Spectrometry and Proteomics
por: Chambers, Matthew C., et al.
Publicado: (2012)

Monitoring targeted drug delivery: a key cornerstone of precision medicine
por: Marko-Varga, György, et al.
Publicado: (2012)

The Path to Clinical Proteomics Research: Integration of Proteomics, Genomics, Clinical Laboratory and Regulatory Science
por: Boja, Emily S., et al.
Publicado: (2011)

Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery
por: Havugimana, Pierre C., et al.
Publicado: (2022)

MSIWarp: A General Approach to Mass Alignment in Mass Spectrometry Imaging
por: Eriksson, Jonatan O., et al.
Publicado: (2020)

The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science
por: Ansari, Daniel, et al.
Publicado: (2014)

Automated Sample Preparation Platform for Mass Spectrometry-Based Plasma Proteomics and Biomarker Discovery
por: Guryča, Vilém, et al.
Publicado: (2014)

Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens
por: Whiteaker, Jeffrey R., et al.
Publicado: (2021)

Standardizing Proteomics Workflow for Liquid Chromatography-Mass Spectrometry: Technical and Statistical Considerations
por: Srivastava, Sudhir, et al.
Publicado: (2019)

Considerations for defining +80 Da mass shifts in mass spectrometry-based proteomics: phosphorylation and beyond
por: Daly, Leonard A., et al.
Publicado: (2023)

An analytical platform for mass spectrometry-based identification and chemical analysis of RNA in ribonucleoprotein complexes
por: Taoka, Masato, et al.
Publicado: (2009)

ProHits: an integrated software platform for mass spectrometry-based interaction proteomics
por: Liu, Guomin, et al.
Publicado: (2010)

Proteomic Workflows for Biomarker Identification Using Mass Spectrometry — Technical and Statistical Considerations during Initial Discovery
por: Orton, Dennis J., et al.
Publicado: (2013)

Targeted mass-spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP kinase, and AKT signaling
por: Whiteaker, Jeffrey R., et al.
Publicado: (2021)

Merging clinical chemistry biomarker data with a COPD database - building a clinical infrastructure for proteomic studies
por: Eriksson, Jonatan, et al.
Publicado: (2017)

MetaProD: A Highly-Configurable Mass Spectrometry Analyzer for Multiplexed Proteomic and Metaproteomic Data
por: Canderan, Jamie, et al.
Publicado: (2023)

Proteomics and Mass Spectrometry for Cancer Biomarker Discovery
por: Lu, Ming, et al.
Publicado: (2007)

Assessment of Sample Preparation Bias in Mass Spectrometry-Based Proteomics
por: Klont, Frank, et al.
Publicado: (2018)

Clusterwise Peak Detection and Filtering Based on Spatial Distribution To Efficiently Mine Mass Spectrometry Imaging Data
por: Eriksson, Jonatan O., et al.
Publicado: (2019)

Comprehensive mass spectrometry based biomarker discovery and validation platform as applied to diabetic kidney disease
por: Bringans, Scott D., et al.
Publicado: (2017)

An Integrated Mass Spectrometry-Based Glycomics-Driven Glycoproteomics Analytical Platform to Functionally Characterize Glycosylation Inhibitors
por: Alvarez, Michael Russelle S., et al.
Publicado: (2022)

Mass spectrometry for translational proteomics: progress and clinical implications
por: Baker, Erin Shammel, et al.
Publicado: (2012)

Antithrombin diagnostics by mass spectrometry: Development and analytical validation of a next-generation test
por: Kruijt, Mirjam, et al.
Publicado: (2023)

Mass Spectrometry-Based Proteomics for Pre-Eclampsia and Preterm Birth
por: Law, Kai P., et al.
Publicado: (2015)

Biobank resources for future patient care: developments, principles and concepts
por: Végvári, Ákos, et al.
Publicado: (2011)

Proteome discovery pipeline for mass spectrometry-based proteomics
por: Gough, Erik, et al.
Publicado: (2008)

mspire: mass spectrometry proteomics in Ruby
por: Prince, John T., et al.
Publicado: (2008)

Computational Mass Spectrometry–Based Proteomics
por: Käll, Lukas, et al.
Publicado: (2011)

Comparing cellular proteomes by mass spectrometry
por: Fröhlich, Florian, et al.
Publicado: (2009)

Urine Proteomics in the Era of Mass Spectrometry
por: Beasley-Green, Ashley
Publicado: (2016)

Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes
por: Ragulan, Chanthirika, et al.
Publicado: (2019)

Mass spectrometry in epidemiological studies: What are the key considerations?
por: Dehghan, Abbas
Publicado: (2016)

A proteomic profiling of laser-microdissected lung adenocarcinoma cells of early lepidic-types
por: Kato, Yasufumi, et al.
Publicado: (2015)

Proteomic Analysis and Discovery Using Affinity Proteomics and Mass Spectrometry
por: Olsson, Niclas, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_dgin4fm6qod5e9h549g3rof6km